RxDoctor Payments Data

Melissa Rodgers, MD

Family Medicine · Alcoa, TNNPI 1205009081

Payments from drug & device makers

$925in general payments, 2019–2025

Across 56 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$203
  • Novo Nordisk$154
  • AstraZeneca$144
  • GSK$136
  • AbbVie$62
  • Amgen$56
  • plus $169 from 7 others

What the payments were for

  • Food & beverage$925100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$925 in reported general payments places this provider in the 55th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$60,939
Medicare patients
180
Services billed
783

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide142$232,114
Trelegy ElliptaFluticasone/Umeclidin/Vilanter89$77,011
TrulicityDulaglutide40$55,016
OzempicSemaglutide39$53,215
EliquisApixaban37$50,257
JardianceEmpagliflozin34$38,361
MyrbetriqMirabegron36$32,566
Breo ElliptaFluticasone/Vilanterol41$29,539
XareltoRivaroxaban31$28,260
FarxigaDapagliflozin Propanediol16$15,904
Aimovig AutoinjectorErenumab-Aooe12$9,290
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$5,072
Omeprazole288$3,892
Atorvastatin Calcium415$3,831
Gabapentin221$3,632

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$203$287,130182 claims
GSKTrelegy Ellipta, Breo Ellipta$136$106,550130 claims
Novo NordiskOzempic$154$53,21539 claims
PfizerEliquis$33$50,25737 claims
Boehringer IngelheimJardiance$14$38,36134 claims
Johnson & JohnsonXarelto$33$28,26031 claims
AstraZenecaFarxiga$144$15,90416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Alcoa

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →